{"product_id":"uw-medicine-16th-annual-comprehensive-hematology-oncology-review-course-2025","title":"UW Medicine 16th Annual Comprehensive Hematology \u0026 Oncology Review Course 2025","description":"\u003ch1 class=\"product_title entry-title\"\u003eUW Medicine 16th Annual Comprehensive Hematology \u0026amp; Oncology Review Course 2025\u003c\/h1\u003e\r\n\u003cstrong\u003e+ Include: 54 Videos (.mp4) + 54 Subtitles (.vtt) + 56 PDFs, size: 27.77 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Target Audience: hematologists, oncologists\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003ch2 data-path-to-node=\"0\"\u003e1. Overview\u003c\/h2\u003e\r\n\u003cp data-path-to-node=\"1\"\u003eThe UW Medicine 16th Annual Comprehensive Hematology \u0026amp; Oncology Review Course 2025 delivers an extensive update on the standard of care for blood disorders and malignancies. This course synthesizes the latest clinical data, treatment guidelines, and therapeutic advances to optimize patient management in both hematology and oncology practice.\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"1\"\u003eMonday, October 6, 2025, 7:00 AM – Friday, October 10, 2025, 5:00 PM, Other, Seattle, WA\u003c\/p\u003e\r\n\r\n\u003ch2 data-path-to-node=\"2\"\u003e2. Learning Objectives\u003c\/h2\u003e\r\n\u003cul data-path-to-node=\"3\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,0,0\"\u003eEvaluate recent advances in the management of acute and chronic leukemias, lymphomas, and multiple myeloma.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,1,0\"\u003eApply updated treatment algorithms for solid tumors including breast, lung, GI, GU, and gynecologic cancers.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,2,0\"\u003eIntegrate new pharmacological agents and immunotherapies into clinical practice for better patient outcomes.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,3,0\"\u003eIdentify and manage complications of cancer treatments, including thrombosis and infectious diseases.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,4,0\"\u003eDiscuss evolving strategies in supportive care, transfusion medicine, and hematopoietic cell transplantation.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-path-to-node=\"4\"\u003e3. Target Audience\u003c\/h2\u003e\r\n\u003ch2 data-path-to-node=\"4\"\u003e\u003cspan style=\"color: #555555; font-size: 14.4px;\"\u003eBest for hematologists and oncologists who want comprehensive updates on diagnosing and treating blood disorders and solid tumors.\u003c\/span\u003e\u003c\/h2\u003e\r\n\u003ch2 data-path-to-node=\"6\"\u003e4. Topics\u003c\/h2\u003e\r\n\u003cul data-path-to-node=\"8\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,0,0\"\u003eAcute Lymphoblastic Leukemia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,1,0\"\u003eAcute Myeloid Leukemia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,2,0\"\u003eAdjuvant Therapy for Breast Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,3,0\"\u003eAnal Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,4,0\"\u003eBenign White Cell Disorders\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,5,0\"\u003eBladder Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,6,0\"\u003eBleeding Disorders\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,7,0\"\u003eB-NHL, Aggressive Non-Hodgkin Lymphoma\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,8,0\"\u003eB-NHL, Indolent Non-Hodgkin Lymphoma\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,9,0\"\u003eCholangiocarcinoma\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,10,0\"\u003eChronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) \u0026amp; Hairy Cell Leukemia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,11,0\"\u003eChronic Myeloid Leukemia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,12,0\"\u003eCNS Cancers\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,13,0\"\u003eColorectal Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,14,0\"\u003eConsultative Hematology\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,15,0\"\u003eEsophageal-Gastric Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,16,0\"\u003eFamilial Syndromes\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,17,0\"\u003eGastrointestinal Neuroendocrine Tumors\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,18,0\"\u003eGynecologic Oncology – Cervical and Endometrial Cancers\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,19,0\"\u003eGynecologic Oncology – Ovarian Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,20,0\"\u003eHead, Neck and Thyroid Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,21,0\"\u003eHematology Pharmacology Pearls\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,22,0\"\u003eHematopoietic Cell Transplantation\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,23,0\"\u003eHepatocellular Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,24,0\"\u003eHodgkin Lymphoma\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,25,0\"\u003eInfectious Disease Complications\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,26,0\"\u003eInherited \u0026amp; Acquired Marrow Failure\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,27,0\"\u003eIntegrative Medicine\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,28,0\"\u003eIron Metabolism Disorders \u0026amp; Hemolytic Anemias\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,29,0\"\u003eMelanoma and Other Skin Cancers\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,30,0\"\u003eMesothelioma\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,31,0\"\u003eMetastatic Breast Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,32,0\"\u003eMyelodysplastic Syndromes\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,33,0\"\u003eMyeloproliferative Neoplasms\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,34,0\"\u003eNewly-Diagnosed Myeloma\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,35,0\"\u003eNon-Small Cell Lung Cancer – Adjuvant-Locally Advanced\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,36,0\"\u003eNon-Small Cell Lung Cancer – Metastatic\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,37,0\"\u003ePancreatic Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,38,0\"\u003eProstate Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,39,0\"\u003eRadiation Oncology – Multi-Disciplinary [Breast, Lung, Colorectal, and Palliative]\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,40,0\"\u003eRelapsed-Refractory Myeloma \u0026amp; Amyloidosis\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,41,0\"\u003eRenal Cell Carcinoma\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,42,0\"\u003eSarcoma\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,43,0\"\u003eSmall Cell Lung Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,44,0\"\u003eSmoldering Myeloma \u0026amp; MGUS\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,45,0\"\u003eSolid Tumor Pharmacology Pearls\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,46,0\"\u003eSupportive Care\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,47,0\"\u003eT-Cell Lymphoma – NHL\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,48,0\"\u003eTesticular Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,49,0\"\u003eThalassemia \u0026amp; Hemoglobinopathies\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,50,0\"\u003eTherapy for Non-Invasive Breast Cancer\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,51,0\"\u003eThrombocytopenia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,52,0\"\u003eThrombosis \u0026amp; Anticoagulation\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,53,0\"\u003eTransfusion Medicine\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954563649634,"sku":"MED-AMB06157","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/UW-Medicine-16th-Annual-Comprehensive-Hematology-Oncology-Review-Course-2025.webp?v=1779379780","url":"https:\/\/meducourse.com\/products\/uw-medicine-16th-annual-comprehensive-hematology-oncology-review-course-2025","provider":"Meducourse","version":"1.0","type":"link"}